2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
- PMID: 25747582
- DOI: 10.1016/S0140-6736(14)62049-3
2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
Erratum in
-
Department of Error.Lancet. 2015 May 30;385(9983):2152. doi: 10.1016/S0140-6736(15)60505-0. Epub 2015 May 6. Lancet. 2015. PMID: 26068267 No abstract available.
Abstract
Background: No consensus exists for the best way to monitor and when to trigger delivery in mothers of babies with fetal growth restriction. We aimed to assess whether changes in the fetal ductus venosus Doppler waveform (DV) could be used as indications for delivery instead of cardiotocography short-term variation (STV).
Methods: In this prospective, European multicentre, unblinded, randomised study, we included women with singleton fetuses at 26-32 weeks of gestation who had very preterm fetal growth restriction (ie, low abdominal circumference [<10th percentile] and a high umbilical artery Doppler pulsatility index [>95th percentile]). We randomly allocated women 1:1:1, with randomly sized blocks and stratified by participating centre and gestational age (<29 weeks vs ≥29 weeks), to three timing of delivery plans, which differed according to antenatal monitoring strategies: reduced cardiotocograph fetal heart rate STV (CTG STV), early DV changes (pulsatility index >95th percentile; DV p95), or late DV changes (A wave [the deflection within the venous waveform signifying atrial contraction] at or below baseline; DV no A). The primary outcome was survival without cerebral palsy or neurosensory impairment, or a Bayley III developmental score of less than 85, at 2 years of age. We assessed outcomes in surviving infants with known outcomes at 2 years. We did an intention to treat study for all participants for whom we had data. Safety outcomes were deaths in utero and neonatal deaths and were assessed in all randomly allocated women. This study is registered with ISRCTN, number 56204499.
Findings: Between Jan 1, 2005 and Oct 1, 2010, 503 of 542 eligible women were randomly allocated to monitoring groups (166 to CTG STV, 167 to DV p95, and 170 to DV no A). The median gestational age at delivery was 30·7 weeks (IQR 29·1-32·1) and mean birthweight was 1019 g (SD 322). The proportion of infants surviving without neuroimpairment did not differ between the CTG STV (111 [77%] of 144 infants with known outcome), DV p95 (119 [84%] of 142), and DV no A (133 [85%] of 157) groups (ptrend=0·09). 12 fetuses (2%) died in utero and 27 (6%) neonatal deaths occurred. Of survivors, more infants where women were randomly assigned to delivery according to late ductus changes (133 [95%] of 140, 95%, 95% CI 90-98) were free of neuroimpairment when compared with those randomly assigned to CTG (111 [85%] of 131, 95% CI 78-90; p=0.005), but this was accompanied by a non-significant increase in perinatal and infant mortality.
Interpretation: Although the difference in the proportion of infants surviving without neuroimpairment was non-significant at the primary endpoint, timing of delivery based on the study protocol using late changes in the DV waveform might produce an improvement in developmental outcomes at 2 years of age.
Funding: ZonMw, The Netherlands and Dr Hans Ludwig Geisenhofer Foundation, Germany.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Comment in
-
Delivery of the growth restricted preterm fetus.Lancet. 2015 May 30;385(9983):2126-8. doi: 10.1016/S0140-6736(14)62455-7. Epub 2015 Mar 5. Lancet. 2015. PMID: 25747580 Free PMC article. No abstract available.
-
Delivery of the growth-restricted preterm fetus.Lancet. 2015 Oct 3;386(10001):1336. doi: 10.1016/S0140-6736(15)00327-X. Lancet. 2015. PMID: 26460769 No abstract available.
-
Delivery of the growth-restricted preterm fetus - Author's reply.Lancet. 2015 Oct 3;386(10001):1336. doi: 10.1016/S0140-6736(15)00328-1. Lancet. 2015. PMID: 26460770 No abstract available.
-
Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study.Ultrasound Obstet Gynecol. 2017 Sep;50(3):285-290. doi: 10.1002/uog.18815. Ultrasound Obstet Gynecol. 2017. PMID: 28938063 No abstract available.
Similar articles
-
How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post-hoc analysis of TRUFFLE study.Ultrasound Obstet Gynecol. 2017 Jun;49(6):769-777. doi: 10.1002/uog.17433. Ultrasound Obstet Gynecol. 2017. PMID: 28182335 Clinical Trial.
-
Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study.Ultrasound Obstet Gynecol. 2017 Sep;50(3):347-352. doi: 10.1002/uog.17361. Ultrasound Obstet Gynecol. 2017. PMID: 27854382 Clinical Trial.
-
Longitudinal study of computerized cardiotocography in early fetal growth restriction.Ultrasound Obstet Gynecol. 2017 Jul;50(1):71-78. doi: 10.1002/uog.17215. Ultrasound Obstet Gynecol. 2017. PMID: 27484356 Clinical Trial.
-
Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe.Am J Obstet Gynecol. 2018 Feb;218(2S):S783-S789. doi: 10.1016/j.ajog.2017.12.226. Am J Obstet Gynecol. 2018. PMID: 29422211 Review.
-
Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.Am J Obstet Gynecol. 2022 Mar;226(3):366-378. doi: 10.1016/j.ajog.2021.11.1357. Epub 2022 Jan 10. Am J Obstet Gynecol. 2022. PMID: 35026129 Free PMC article. Review.
Cited by
-
Delivery of the growth restricted preterm fetus.Lancet. 2015 May 30;385(9983):2126-8. doi: 10.1016/S0140-6736(14)62455-7. Epub 2015 Mar 5. Lancet. 2015. PMID: 25747580 Free PMC article. No abstract available.
-
Clinical Assessment of Fetal Well-Being and Fetal Safety Indicators.J Clin Pharmacol. 2022 Sep;62 Suppl 1(Suppl 1):S67-S78. doi: 10.1002/jcph.2126. J Clin Pharmacol. 2022. PMID: 36106777 Free PMC article. Review.
-
Early-onset fetal growth restriction: A systematic review on mortality and morbidity.Acta Obstet Gynecol Scand. 2020 Feb;99(2):153-166. doi: 10.1111/aogs.13702. Epub 2019 Sep 10. Acta Obstet Gynecol Scand. 2020. PMID: 31376293 Free PMC article.
-
Fetal Brain-Sparing, Postnatal Cerebral Oxygenation, and Neurodevelopment at 4 Years of Age Following Fetal Growth Restriction.Front Pediatr. 2020 May 6;8:225. doi: 10.3389/fped.2020.00225. eCollection 2020. Front Pediatr. 2020. PMID: 32435629 Free PMC article.
-
Current practice in the diagnosis and management of fetal growth restriction: An international survey.Acta Obstet Gynecol Scand. 2022 Dec;101(12):1431-1439. doi: 10.1111/aogs.14466. Epub 2022 Oct 10. Acta Obstet Gynecol Scand. 2022. PMID: 36214456 Free PMC article.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous